Everyone's Talking About These 2 Biotech IPO Stocks

Everyone's Talking About These 2 Biotech IPO Stocks

Source: 
Motley Fool
snippet: 
  • Biotech businesses tend to be volatile after their initial public offerings.
  • Kyverna Therapeutics raised more than twice what was initially expected.
  • CG Oncology has plenty of cash, and a mature therapy candidate.